Description:Fluvoxamino Acid, identified by its CAS number 192876-02-1, is a chemical compound that belongs to the class of selective serotonin reuptake inhibitors (SSRIs). It is primarily recognized for its application in the treatment of various psychiatric disorders, particularly obsessive-compulsive disorder (OCD) and depression. The compound exhibits a mechanism of action that involves the inhibition of serotonin reuptake in the brain, thereby increasing serotonin levels in the synaptic cleft and enhancing mood regulation. Fluvoxamino Acid is characterized by its specific molecular structure, which contributes to its pharmacological properties. It is typically administered in oral form and may have side effects, including gastrointestinal disturbances, sleep changes, and potential interactions with other medications. As with many SSRIs, careful monitoring is essential during treatment to manage any adverse effects and to ensure therapeutic efficacy. Research continues to explore its full range of effects and potential applications in mental health treatment.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.